Multiple Sclerosis Symptoms, Diagnosis and Treatment

September 20, 2017September 19, 2017
Sensory Overload Occurring: Please, Do Not Disturb!
Columns, You've Got Some Nerves - A Column By Judy Lynn
The past two weekends found me venturing off on my own for some mini-road trips. Two weeks ago, I ... Read more
September 20, 2017September 19, 2017
Data Differences: Better Records, Better Care
Columns, MS in Motion - A Column by Mike Knight
“I’m sorry, these files take forever to copy,” the woman at the registration desk says, breaking the silence that ... Read more
September 20, 2017September 20, 2017
Winner of $4.9 Million Research Award Tests Online and Teleconference-based Methods to Reduce MS-related Fatigue
News
People with multiple sclerosis (MS) often face geographic barriers that end up limiting their treatment options. That has led a Case ... Read more
September 20, 2017September 20, 2017
ImStem, UConn Obtain U.S. Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases
News
The U.S. Patent and Trademark Office has issued a patent for human embryonic stem cells derived mesenchymal stem cells, ... Read more
September 19, 2017September 18, 2017
Winning with Deuces
Columns, The MS Wire - A Column by Ed Tobias
This is a story about sports. It’s not really about MS, it’s about playing football. But, then again, ... Read more
September 19, 2017September 19, 2017
TG Therapeutics Recruiting Patients for Two Phase 3 Trials of Relapsing MS Therapy TG-1101
News
TG Therapeutics is recruiting participants for two Phase 3 clinical trials that will evaluate the safety and effectiveness of ... Read more
September 18, 2017September 18, 2017
MS Patients Deserve the Best Care
Columns, Faith of the Mustard Seed - a Column by Debi Wilson
As patients, we deserve the best care for our MS and we should accept nothing less. I have had many years ... Read more
September 18, 2017September 18, 2017
MS News That Caught My Eye: Probiotics, Gut Bacteria, Ocrevus, and a Pain Pill
Columns, The MS Wire - A Column by Ed Tobias
Probiotics Consumption May Improve Certain Disease Parameters in MS Patients, Study Suggests Probiotics (bacteria that help move food through ... Read more
September 18, 2017September 19, 2017
Finnish Study Links Low Levels of Vitamin D to Higher Risk of MS in Women
News
Women with low levels of vitamin D in their blood are more likely to develop multiple sclerosis later ... Read more
September 18, 2017September 19, 2017
Synthon Wins EU Patent Case Against Teva, Paving Way for Generic Copaxone for MS Patients
News
A European Patent Office decision has opened the door to Synthon providing cheaper generic versions of Teva Pharmaceutical’s ... Read more
September 15, 2017September 14, 2017
This Too Shall Pass
A Life in Letters -- A Column By Jamie Hughes, Columns
I posted this meme on social media last week with the caption “Current Life Status,” hoping a laugh might help ... Read more
September 15, 2017September 18, 2017
MS and Incontinence
Columns, Fall Down, Get Up Again- a Column by John Connor
Another of those things I was never warned about. Maybe if I’d been assigned a local MS nurse at ... Read more

September 15, 2017September 18, 2017

Probiotics Consumption May Improve Certain Disease Parameters in MS Patients, Study Suggests

Probiotics may improve the health of people with multiple sclerosis (MS) by reducing disability and improving inflammatory and metabolic parameters, an Iranian study shows. Live microorganisms linked to health benefits, ... Read more

September 15, 2017September 18, 2017

Five Research Projects Totaling $38 Million to Compare Effectiveness of MS Treatment Strategies

News

The Patient-Centered Outcomes Research Institute has awarded $38 million in grants for five projects that compare the effectiveness of different multiple sclerosis treatment strategies. A key aim of the research ... Read more

September 14, 2017September 15, 2017

Ocrevus Less Expensive, More Efficient than Interferon, Analysis Reveals

News

Ocrevus is a less expensive treatment option for relapsing multiple sclerosis than Rebif in the long-run, according to a cost-effectiveness analysis published in the Journal of Medical Economics. In addition ... Read more

September 14, 2017September 14, 2017

Specific Gut Bacteria May Drive Progression of Multiple Sclerosis, Study Finds

News

Specific gut bacteria may drive the progression of multiple sclerosis, according to a study showing that two bacterial species made the disease worse in a mouse model of MS. ... Read more

September 13, 2017September 14, 2017

Cognitive Impairment Worse Among PPMS Than RRMS Patients, German Study Finds

News

Patients with primary progressive multiple sclerosis have more severe cognitive impairment than those with relapsing-remitting multiple sclerosis, according to a German study that analyzed published data on the topic. PPMS ... Read more

September 13, 2017September 14, 2017

GT Biopharma to Develop New PainBrake Tablet Formulation to Treat MS Neuropathic Pain

News

GT Biopharma has acquired licensing and development rights for PainBrake — Accu-Break Pharmaceuticals’ non-opioid pain medication to treat dysesthesia and pain caused by nerve damage in multiple sclerosis. Currently ... Read more

September 12, 2017September 13, 2017

Concussion in Adolescence May Increase Risk of MS Later, Swedish Study Suggests

News

Having a concussion when you’re 11 to 20 years old could increase your risk of developing multiple sclerosis later, a Swedish study suggests. The collaboration between Örebro University and Karolinska ... Read more

September 12, 2017September 13, 2017

Swedish Study Suggests Stem Cell Transplants as Possible Treatment for Aggressive RRMS

News

Autologous hematopoietic stem cell transplants for relapsing-remitting multiple sclerosis are superior to currently approved disease-modifying drugs, according to a Swedish study published in the Journal of Neurology, Neurosurgery & ... Read more

September 11, 2017September 12, 2017

MS Humorist Yvonne DeSousa, in GeneFo Webinar, Offers Tips on How Laughter Can Make You Feel Better

News

Laughter really is among the best medicines when it comes to multiple sclerosis, says Yvonne deSousa, an MS patient, humorist and author who plans to share her tips on ... Read more

September 11, 2017September 12, 2017

Structural Eye Neurodegeneration Common Among MS Patients with Optic Neuritis, Danish Study Finds

News

Structural changes of the eye retina are a common feature among multiple sclerosis patients with a clinical history of optic neuritis, a Danish study finds. Loss of the myelin protective ... Read more

September 8, 2017September 11, 2017

US Hispanics Sought for Study of the Roles That Genetics and Culture Play in Severity of MS

News

University of Southern California researchers are recruiting 400 Hispanics who have been diagnosed with multiple sclerosis in the past two years for a study about genetics’ and cultural perceptions’ ... Read more

September 8, 2017September 11, 2017

Two Australians Win Fellowship Aimed at Breaking Barriers Between Basic and Therapy-development Research

News

Two researchers at the University of Tasmania’s Menzies Institute for Medical Research have received an innovative multiple sclerosis research fellowship that was created to drive basic scientific research into ... Read more

September 7, 2017September 9, 2017

Merck Extension Study Confirms Mavenclad’s Long-term Benefits in Relapsing MS Patients

News

Three-fourths of relapsing multiple sclerosis patients who took two short courses of Mavenclad over two years remained relapse-free for four years, according to newly published data from the medication’s ... Read more

September 7, 2017September 9, 2017

#MSParis2017 – Gilenya Reduces Relapses in Children and Adolescents with MS, Novartis Trial Shows

News

Gilenya decreased relapses in children and adolescents with multiple sclerosis in the phase 3 PARADIGMS trial, according to the therapy’s developer, Novartis. The Swiss company will present the trial’s results ... Read more

September 6, 2017September 6, 2017

Older Women with MS Age Better Than Their Male Counterparts, Canadian Survey Finds

News

Older men with multiple sclerosis (MS) have more harmful lifestyles than older women with the disease, concludes the Canadian Survey of Health, Lifestyle and Aging with Multiple Sclerosis. Treatment for depression ... Read more

September 6, 2017September 7, 2017

Dignity, Quest to Jointly Produce ‘Timo Solution’ to Manage Urinary Incontinence

News

Dignity Medical Solutions and Quest Specialty Products will jointly market the “Timo Solution” – a novel technology to manage urinary incontinence, a condition that frequently affects patients with multiple ... Read more

September 5, 2017September 6, 2017

MS Society of Canada Creates ‘Wellness Toolbox’ to Help Patients Manage Their Disease

News

The Multiple Sclerosis Society of Canada — with input from both experts and patients — has developed a “wellness toolbox” with strategies to help multiple sclerosis (MS) patients cope ... Read more

September 5, 2017September 6, 2017

#MSParis2017 – TG Therapeutics to Discuss Ublituximab’s Effectiveness at ECTRIMS–ACTRIMS Meeting in Paris

News

TG Therapeutics will discuss ublituximab’s ability to deplete B-cells linked to multiple sclerosis and to reduce inflammatory brain lesions at the 7th Joint ECTRIMS–ACTRIMS Meeting in Paris next month. The ... Read more